Related Experiment Video
Updated: Jun 11, 2025
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
34.7K
Neuro-Behçet Disease Presenting as a Bulbar Lesion: A Case Report
Mariana Certal1, Ana Sofia Alves2, Marta B Santos1
1Internal Medicine, Unidade Local de Saúde (ULS) de Trás-os-Montes e Alto Douro, Chaves, PRT.
Cureus
|September 30, 2024
Summary
Neuro-Behçet (NB), a neurological complication of Behçet's disease, can cause severe symptoms. Early diagnosis and treatment with corticosteroids and immunosuppressants led to significant improvement in a patient with NB.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Behçet's disease (BD) is a multisystem inflammatory disorder.
- Neuro-Behçet (NB) is a neurological manifestation of BD, impacting the central nervous system.
Observation:
- A 46-year-old female with diagnosed BD presented with acute neurological deficits including posterior cervical pain, ptosis, anisocoria, hemiparesis, hemihypoesthesia, dysmetria, and postural instability.
- Cerebral MRI revealed a right laterobulbar T2 hyperintense lesion, indicative of NB.
Findings:
- The patient received high-dose methylprednisolone pulses followed by azathioprine therapy.
- Clinical symptoms progressively improved, and the bulbar lesion showed resolution on follow-up imaging.
Implications:
- This case underscores the critical role of prompt diagnosis in managing NB.
- Early initiation of appropriate immunosuppressive therapy is vital for favorable patient outcomes in neuro-Behçet.
Related Concept Videos
01:37Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
01:15Parkinson's Disease: Overview
492
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
492